OncoSec Medical (NASDAQ: ONCS)
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of OncoSec Medical (NASDAQ: ONCS) through any online brokerage.
Other companies in OncoSec Medical’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Cabaletta Bio (NASDAQ:CABA), Brooklyn (NASDAQ:BTX) and Monopar Therapeutics (NASDAQ:MNPR).
The latest price target for OncoSec Medical (NASDAQ: ONCS) was reported by BTIG on Wednesday, March 16, 2022. The analyst firm set a price target for 5.00 expecting ONCS to rise to within 12 months (a possible 568.09% upside). 1 analyst firms have reported ratings in the last year.
The stock price for OncoSec Medical (NASDAQ: ONCS) is $0.7484 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for OncoSec Medical.
OncoSec Medical’s Q3 earnings are confirmed for Tuesday, June 14, 2022.
There is no upcoming split for OncoSec Medical.
OncoSec Medical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.